Production and characterization of an anti-(MUC1 mucin) recombinant diabody

Cancer Immunology Immunotherapy

Volumn 48, Issue 1, 1999, Pages 29-38

  Denton, Graeme ^a   Brady, Kevin ^a   Lo, Benny K C ^a   Murray, Andrea ^a   Graves, C Rosamund L ^b   Hughes, Owen D M ^b   Tendler, Saul J B ^a   Laughton, Charles A ^a   Price, Michael R ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

Diabody; Immunotherapy; MUC1; Mucin; scFv

Indexed keywords

GLYCOPROTEIN; IMMUNOGLOBULIN FRAGMENT; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY C595; MUCIN; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANTIGEN BINDING; ARTICLE; CANCER IMMUNOLOGY; CANCER IMMUNOTHERAPY; CELL SURFACE; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; SEQUENCE ANALYSIS;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, BISPECIFIC; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; CA-15-3 ANTIGEN; DIMERIZATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN FRAGMENTS; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; PROTEIN CONFORMATION; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; TUMOR CELLS, CULTURED;

EID: 0032919498     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050545     Document Type: Article

References (31)

1. 1. Adams GP, Schier R, Mccall AM, Crawford RS, Wolf EJ, Weiner LM, Marks JD (1998) Prolonged in vivo tumour retention of a human diabody targeting the extracellular domain of human HER2/neu . Br J Cancer 77:1405
2. 2. Begent RH, Verhaar MJ, Chester CA, Casey JL, Green AJ, Napier MP, Hope-Stone LD, Cushen N, Keep PA, Johnson CJ, Hawkins RE, Hilson AJ, Robson L (1996) Clinical evidence of efficient tumour targeting based upon single-chain Fv antibody selected from a combinatorial library. Nat Med 2:979
3. 3. Berruti A, Tampellini M, Torta M, Buniva T, Gorzegno G, Dogliotti L (1994) Prognostic value in predicting overall survival of two mucinous markers: CA 15-3 and CA 125 in breast cancer patients at first relapse of disease. Eur J Cancer 30A:2082
4. 4. Denton G, Sekowski M, Spencer DIR, Hughes ODM, Murray A, Denley H, Tendler SJB, Price MR (1997) Production and characterization of a recombinant anti-MUC1 scFv reactive with human carcinomas. Br J Cancer 76:614
5. 5. Dixon AR, Price MR, Hand CW, Sibley PEC, Selby C, Blamey RW (1993) Epithelial mucin core antigen (EMCA) in assessing therapeutic response in advanced breast cancer - a comparison with CA15.3, Br J Cancer 68:947
6. 6. Domenech N, Henderson RA, Finn OJ (1995) Identification of an HLA-A11 restricted epitope from the tandem repeat domain of the epithelial tumour-antigen mucin. J Immunol 155:4766
7. 7. Gendler S, Taylor-Papadimitriou J, Duhig T, Rothbard J, Burchell J (1988) A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats. J Biol Chem 263:12820
8. 8. Gendler SJ, Spicer AP, Lalani AL, Duhig T, Peat N, Burchell J, Pemberton M (1991) Structure and biology of a carcinoma-associated mucin, MUC1. Am Rev Respir Dis 144:S42
9. 9. Holliger P, Prospero T, Winter G (1993) "Diabodies": small bivalent and bispecific antibody fragments. Proc Natl Acad Sci USA 90:6444
10. 67Cu-labelled anti-MUC1 mucin for therapeutic use in bladder cancer. Eur J Nucl Med 24:439
11. 11. Jerome KR, Barnd DL, Bendt KM, Boyer CM, Taylor-Papadimitriou J, McKenzie IFC, Bast RC, Finn OJ (1991) Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognise an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells. Cancer Res 51:2908
12. 12. Kotera Y, Fontenot JD, Pecher G, Metzgar RS, Finn OJ (1994) Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic and colon cancer patients. Cancer Res 54:2856
13. 13. Kunkler RB, Bishop MC, Green DJ, Pimm MV, Price MR, Frier M (1995) Targeting of bladder cancer with radiolabelled monoclonal antibody NCRC-48 - a novel approach for intravesical therapy. Br J Urol 75:9
14. 14. Kurucz I, Titus JA, Jost CR, Jacobus CM, Segal DM (1995) Retargeting of CTL by an efficiently refolded bispecific single chain Fv dimer produced in bacteria. J Immunol 154:4576
15. 15. Luo D, Mah N, Krantz M, Wishart D, Jacobs F, Maritin L (1997) High level secretion of single-chain antibody in Pichia expression system. Biotechnol Tech 11:759
16. 16. Mack M, Riethmuller G, Kufer P (1995) A small bispecific antibody construct expressed as a functional single-chain molecule with high tumor cell cytotoxicity. Proc Natl Acad Sci USA 92:7021
17. 17. Mallender WD, Voss EW Jr (1994) Construction, expression and activity of a bivalent bispecific single-chain antibody. J Biol Chem 269:199
18. 18. Martoni A, Zamagni C, Bellanova B, Zanichelli L, Vecchi F, Cacciari N, Strocchi E, Pannuti F (1995) CEA, MCA CA 15.3 and CA 549 and their combinations in expressing and monitoring metastatic breast cancer: a prospective comparative study. Eur J Cancer 31:1615
19. 19. McCafferty J, Griffiths AD, Winter G, Chiswell DJ (1990) Phage antibodies: filamentous phage displaying antibody variable domains. Nature 348:552
20. 20. O'Sullivan C, Price MR, Baldwin RW (1990) Polymorphic epithelial mucin from the sera of advanced breast cancer patients-isolation and partial characterisation. Br J Cancer 61:801
21. 21. Pack P, Pluckthun A (1992) Miniantibodies: use of amphipathic helices to produce functional, flexibly linked dimeric Fv fragments with high avidity in Escherichia coli. Biochem 31:1579
22. 22. Perkins AC, Symonds IM, Pimm MV, Price MR, Wastie ML, Symonds EM (1993) Immunoscintigraphy of ovarian carcinoma using a monoclonal antibody (In-111-NCRC-48) defining polymorphic epithelial mucin. Nucl Med Commun 14:578
23. 23. Price MR, Tendler SJB (1993) Polymorphic epithelial mucins (PEM): molecular characteristics and association with breast cancer. Breast 2:3
24. 24. Price MR, Pugh JA, Hudecz F, Griffiths W, Jacobs E, Clarke AJ, Chan WC, Baldwin RW (1990) C595 - a monoclonal antibody against the protein core of human urinary epithelial mucin commonly expressed in breast carcinomas. Br J Cancer 61:681
25. 25. Price MR, Sekowski M, Tendler SJB (1991) Purification of anti-epithelial mucin monoclonal antibodies by epitope affinity chromatography. J Immunol Methods 139:83
26. 26. Price MR, Briggs S, Scanlon MJ, Tendler SJB, Sibley PEC, Hand CW (1992) The mucin antigens - what are we measuring? Dis Markers 9:205
27. 27. Rughetti A, Turchi V, Ghetti CA, Scambia G, Panici PB, Roncucci G, Mancuso SM, Frati L, Nuti M (1993) Human B-cell immune response to the polymorphic epithelial mucin. Cancer Res 53:2457
28. 28. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor Press, Cold Spring Harbor, NY
29. 29. Symonds IM, Price MR, Pimm MV, Perkins AC, Wastie ML, Baldwin RW, Symonds EM (1992) Preliminary report of tumour localisation and imaging of ovarian neoplasia with a new monoclonal antibody raised against urinary mucin. In: Klapdor R (ed), Tumour associated antigens, oncogenes, receptors, cytokines in tumour diagnosis and therapy at the beginning of the nineties. Zuckschwerdt, Munchen, p 572
30. 30. Wu AM, Chen W, Raubitschek A, Williams LE, Neumaier M, Fischer R, Hu SZ, Odommaryon T, Wong JYC, Shively JE (1996) Tumor localization of anti-CEA single-chain Fvs: improved targeting by non-covalent dimers. Immunotechnology 2:21
31. 31. Yokota T, Milenic DE, Whitlow M, Schlom J (1992) Rapid tumor penetration of a single chain Fv and comparison with other immunoglobulin forms. Cancer Res 52:3402